Groupe la Francaise Decreases Holdings in Synopsys, Inc. $SNPS

Groupe la Francaise cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 7.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 35,945 shares of the semiconductor company’s stock after selling 2,856 shares during the period. Groupe la Francaise’s holdings in Synopsys were worth $16,142,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after buying an additional 346,994 shares during the last quarter. Pictet Asset Management Holding SA raised its stake in Synopsys by 38.3% during the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock valued at $1,043,518,000 after buying an additional 673,837 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Synopsys by 6.6% during the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock valued at $863,500,000 after buying an additional 125,199 shares during the last quarter. Nuveen Asset Management LLC increased its stake in shares of Synopsys by 12.1% in the 4th quarter. Nuveen Asset Management LLC now owns 1,691,501 shares of the semiconductor company’s stock worth $820,987,000 after purchasing an additional 182,115 shares in the last quarter. Finally, Northern Trust Corp increased its stake in shares of Synopsys by 14.6% in the 4th quarter. Northern Trust Corp now owns 1,639,587 shares of the semiconductor company’s stock worth $795,790,000 after purchasing an additional 209,031 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Trading Up 1.4%

Shares of SNPS stock opened at $606.52 on Friday. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. The firm has a market capitalization of $94.11 billion, a PE ratio of 43.79, a PEG ratio of 3.93 and a beta of 1.15. The stock has a fifty day simple moving average of $570.29 and a two-hundred day simple moving average of $500.95.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter in the prior year, the firm earned $3.00 EPS. The business’s revenue was up 10.3% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. On average, analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the completion of the transaction, the chief financial officer owned 15,291 shares of the company’s stock, valued at $7,427,144.52. This represents a 32.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the transaction, the chief executive officer directly owned 71,589 shares of the company’s stock, valued at $32,782,750.77. This trade represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,686 shares of company stock valued at $13,001,048 in the last 90 days. Insiders own 0.62% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on SNPS shares. Piper Sandler upped their price objective on Synopsys from $615.00 to $660.00 and gave the stock an “overweight” rating in a research note on Monday, July 21st. Morgan Stanley restated an “overweight” rating and issued a $715.00 price objective (up from $540.00) on shares of Synopsys in a research note on Monday, August 11th. KeyCorp upped their price objective on Synopsys from $540.00 to $610.00 and gave the stock an “overweight” rating in a research note on Thursday, July 10th. Rosenblatt Securities upped their price objective on Synopsys from $625.00 to $650.00 and gave the stock a “buy” rating in a research note on Friday, July 25th. Finally, The Goldman Sachs Group started coverage on Synopsys in a research note on Thursday, July 10th. They issued a “buy” rating and a $620.00 price objective for the company. Twelve investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Synopsys currently has an average rating of “Moderate Buy” and a consensus price target of $626.79.

View Our Latest Stock Report on Synopsys

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.